Effects of metronidazole combined probiotics over metronidazole alone for the treatment of bacterial vaginosis: a meta-analysis of randomized clinical trials
- 1.1k Downloads
To evaluate the curative effect of metronidazole combined probiotics over metronidazole alone in the treatment of BV.
We are searching randomized controlled trials on major online databases including PubMed, Science Direct, and Cochrane Database between 1990 and 2015. The primary outcome measure was the cure rate of BV. Cochran’s Chi-square test (Q test) was used to test for heterogeneity among trials, and the I 2 index. We used mixed-effects modeling for parameters of the summary hazard ratios (HRs), odds ratios (ORs), and their 95% confidence intervals (CIs).
Analysis suggests the cure rate of BV [RR = 1.12, 95% CI (0.94–1.32), p = 0.20], and the I 2 index was 83%. The value of I 2 index decreased to 16% after removing the study of Anukam et al., and Amsel 1.04 (95% CI 0.96–1.13) (p = 0.35), Nugent 1.02 (95% CI 0.94–1.11), short-term 1.01 (95% CI 0.93–1.10) (p = 0.79), long-term 1.06 (95% CI 0.98–1.14) (p = 0.13), Europe 1.06 (95% CI 0.95–1.19) (p = 0.32), Non-Europe 0.99 (95% CI 0.94–1.05) (p = 0.83). When the two same groups data were combined, respectively, the RRs for all studies were the same as 1.03 (95% CI 0.96–1.09) (p = 0.42) showing that there is not statistically significant in relevant stratums.
The result has showed an overall little significance for the efficacy of metronidazole combined probiotics over metronidazole alone for the treatment of BV. We need more further studies to provide enough evidence to confirm the benefits of probiotics in the treatment of BV.
KeywordsBacterial vaginosis Meta-analysis Probiotics Metronidazole
Compliance with ethical standards
Conflict of interest
All authors declare no conflicts of interest. We have had full control of all primary data and we agree to allow the Journal to review their data if requested.
HT: Resources, Data Collection, Data analysis, Manuscript writing. YF: Data analysis, Manuscript writing. CY: Data analysis, Manuscript writing. JM: Resources, Manuscript writing, Supervision.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 4.Sobel JD (2000) Bacterial vaginosis[J]. Medicine (Baltimore) 71 (51):349–356Google Scholar
- 18.Ozmen S, Turhan NO, Seckin NC (1998) Gardnerella-associated vaginitis: Comparison of three treatment modalities[J]. Turk J Med Sci 2:171–174Google Scholar
- 22.Anukam K, Osazuwa E, Ahonkhai I et al (2006) Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial[J]. Microbes Infect 8 (6):1450–1454CrossRefPubMedGoogle Scholar
- 24.Blackwell AL, Phillips I, Fox AR et al (1984) Anaerobic vaginosis (non-specific vaginitis): clinical, microbiological, and therapeutic findings[J]. Lancet 2 (8364):1379–1382Google Scholar
- 30.Shu-Ning LI, Huang GL, Qun-Shan XU et al (2012) Analysis of vaginal secretion detection results of 13102 cases by combination of routine examination and BV 3-in -1 test[J]. Chin J Health Lab Technol 22(8):1880–1882Google Scholar
- 31.Senok AC, Verstraelen H, Temmerman M et al (2009) Probiotics for the treatment of bacterial vaginosis[J]. Cochrane Database Syst Rev 4:CD006289–CD006289Google Scholar
- 40.Hughes VL, Hillier SL (1990) Microbiologic characteristics of Lactobacillus products used for colonization of the vagina[J]. Obstetr Gynecol 75 (2):244–248Google Scholar
- 42.Shen DS (2012) Microecology, bacterial vaginosis and probiotics[J]. Chin J Microecol 24 (6):570–572Google Scholar